# Dutasteride + Tamsulosin

## Duodart 0.5/0.4mg

#### 一般可用

| 藥品代碼       | ODUO                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|:---------------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症         | Benign prostatic hyperplasia: Treatment of symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate                                                                                                                                                                                                                                                                                                                                   |
| 用法用量       | The recommended dose of Duodart is 1 capsule daily (0.5 mg / 0.4 mg). Duodart must always be taken with a glass of water， up to 30 minutes after a meal. It must never be taken on an empty stomach. Ideally， it should be taken at the same time of the day (this means with the same meal). The capsules should be swallowed whole and not chewed or opened， as contact with the capsule contents may result in irritation of the oropharyngeal mucosa. |
| 肝功能異常     | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| 腎功能異常     | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| 禁忌           | Hypersensitivity (clinically significant) to dutasteride， tamsulosin， other 5-alpha-reductase inhibitors (eg， finasteride)， or any component of the formulation; children; women of childbearing potential; pregnancy                                                                                                                                                                                                                                    |
| 副作用         | 1% to 10%: Central nervous system: Dizziness (2%) Endocrine & metabolic: Decreased libido (5% to 6%)， breast changes (3% to 5%， including enlargement， swelling， pain， tenderness， gynecomastia， nipple pain， nipple swelling) Genitourinary: Ejaculatory disorder (10% to 11%)， impotence (8% to 10%) <1% (Limited to important or life-threatening): Prostate cancer (high-grade)                                                                 |
| 孕期用藥建議   | Uknown 沒有資料                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 哺乳期用藥建議 | No (Limited) Human Data – Potential Toxicity(Mother) 無(很少)資料 – 避免使用(母體)                                                                                                                                                                                                                                                                                                                                                                           |

